BENEPHARMA
0685.992.809 · rovalta.com · 22/09/2026
BENEPHARMA
Overview
What does BENEPHARMA do?
BENEPHARMA is a Private company with limited liability incorporated in 2017. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Overijse. It employs on average 2,2 ETP workers (FTE).
3090 Overijse · FlandreSee on map
Joint committees (1)
- 313
Trend over 8 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||
| Gross margin | 471,9 k € | +10.9% | 425,7 k € | +21.3% | 350,8 k € | +16.0% | 302,3 k € | +16.2% | 260,1 k € | +7.2% | 242,6 k € | +6.0% | 228,8 k € | +36.0% | 168,3 k € |
| EBITDA | 317,7 k € | +15.6% | 274,7 k € | +54.2% | 178,1 k € | +4.1% | 171,2 k € | +16.0% | 147,6 k € | -3.1% | 152,2 k € | +32.7% | 114,7 k € | +194% | 39 k € |
| Operating result | 242,8 k € | +20.1% | 202,1 k € | +90.8% | 105,9 k € | -5.8% | 112,4 k € | +23.6% | 90,9 k € | +38.0% | 65,9 k € | +201% | 21,9 k € | +966% | -2,5 k € |
| Net result | 161,7 k € | +19.4% | 135,5 k € | +92.9% | 70,2 k € | -8.8% | 77 k € | -7.8% | 83,5 k € | +10.0% | 75,9 k € | +57.6% | 48,2 k € | +77.2% | 27,2 k € |
| Balance sheet | |||||||||||||||
| Equity | 459,1 k € | -9.1% | 504,8 k € | +28.0% | 394,4 k € | +21.7% | 324,1 k € | +31.2% | 247,1 k € | +51.0% | 163,6 k € | +86.5% | 87,7 k € | +122% | 39,6 k € |
| Total assets | 813,9 k € | -7.1% | 876,2 k € | +11.5% | 785,9 k € | +8.2% | 726,3 k € | +2.6% | 708 k € | -3.0% | 729,9 k € | -15.5% | 863,6 k € | +11.4% | 775,3 k € |
| Cash | 138,4 k € | -17.6% | 168,1 k € | +325% | 39,5 k € | -41.9% | 68,1 k € | +18.7% | 57,4 k € | +34.4% | 42,7 k € | -61.9% | 111,9 k € | -26.6% | 152,5 k € |
| Debts | 351,7 k € | -4.5% | 368,3 k € | -5.3% | 388,8 k € | -2.5% | 398,6 k € | -13.0% | 458,2 k € | -18.4% | 561,9 k € | -27.4% | 773,8 k € | +5.9% | 730,5 k € |
| Other | |||||||||||||||
| Workforce | 2,2 ETP | -18.5% | 2,7 ETP | +3.8% | 2,6 ETP | +36.8% | 1,9 ETP | +18.7% | 1,6 ETP | +14.3% | 1,4 ETP | -17.6% | 1,7 ETP | 0.0% | 1,7 ETP |
Indicative valuation
As an indication, this company is worth
Board of directors
Seen on filing of 31/12/2025 · 1 active · 1 ended
Active mandates
Ended mandates
Financials
Full financial information
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 23/06/2026 | 24/06/2025 | 20/08/2024 | 21/08/2023 | 14/07/2022 | 05/08/2021 |
| General meeting | 19/06/2026 | 20/06/2025 | 21/06/2024 | 16/06/2023 | 17/06/2022 | 18/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Looking for more information about this company?
Try for 7 daysAnnual accounts filings
8 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 19/06/2026 | 23/06/2026 | Dutch | |
| Abridged model | 31/12/2024 | 20/06/2025 | 24/06/2025 | Dutch | |
| Abridged model | 31/12/2023 | 21/06/2024 | 20/08/2024 | Dutch | |
| Abridged model | 31/12/2022 | 16/06/2023 | 21/08/2023 | Dutch | |
| Abridged model | 31/12/2021 | 17/06/2022 | 14/07/2022 | Dutch | |
| Abridged model | 31/12/2020 | 18/06/2021 | 05/08/2021 | Dutch | |
| Abridged model | 31/12/2019 | 19/06/2020 | 01/09/2020 | Dutch | |
| Abridged model | 31/12/2018 | 21/06/2019 | 23/08/2019 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Seen on filing of 31/12/2025 · 1 active · 1 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025161,7 k €↑
- 2024Annual accounts 2024135,5 k €↑
- 2023Annual accounts 202370,2 k €↓
- 2022Annual accounts 202277 k €↓
- 2021Annual accounts 202183,5 k €↑
- 2020Annual accounts 202075,9 k €↑
- 2019Annual accounts 201948,2 k €↑
- 2018Annual accounts 201827,2 k €
- 15/12/2017IncorporationPrivate company with limited liability